CXCR4-targeted theranostics in oncology

AK Buck, SE Serfling, T Lindner, H Hänscheid… - European Journal of …, 2022 - Springer
A growing body of literature reports on the upregulation of CXC motif chemokine receptor 4
(CXCR4) in a variety of cancer entities, rendering this receptor as suitable target for …

Chemokine receptor CXCR4: role in gastrointestinal cancer

L Lombardi, F Tavano, F Morelli, TP Latiano… - Critical reviews in …, 2013 - Elsevier
Chemokines (CK) s, small proinflammatory chemoattractant cytokines that bind to specific G-
protein coupled seven-span transmembrane receptors, are major regulators of cell …

CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy

A Mousavi - Immunology Letters, 2020 - Elsevier
Chemokines are small molecules called “chemotactic cytokines” and regulate many
processes like leukocyte trafficking, homing of immune cells, maturation, cytoskeletal …

Efficacious immunomodulatory activity of the chemokine stromal cell–derived factor 1 (SDF-1): local secretion of SDF-1 at the tumor site serves as T-cell …

K Dunussi-Joannopoulos, K Zuberek… - Blood, The Journal …, 2002 - ashpublications.org
The chemokine stromal cell–derived factor 1 (SDF-1) is essential for perinatal viability, B
lymphopoiesis, and bone marrow myelopoiesis, and is a potent monocyte and T-lymphocyte …

Loss of CXCR4 in myeloid cells enhances antitumor immunity and reduces melanoma growth through NK cell and FASL mechanisms

J Yang, A Kumar, AE Vilgelm, SC Chen, GD Ayers… - Cancer immunology …, 2018 - AACR
The chemokine receptor, CXCR4, is involved in cancer growth, invasion, and metastasis.
Several promising CXCR4 antagonists have been shown to halt tumor metastasis in …

CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation–a target for novel cancer therapy

R Tokunaga, WU Zhang, M Naseem, A Puccini… - Cancer treatment …, 2018 - Elsevier
Chemokines are proteins which induce chemotaxis, promote differentiation of immune cells,
and cause tissue extravasation. Given these properties, their role in anti-tumor immune …

Chemokine CXCL14; a double-edged sword in cancer development

AG Shabgah, ZH Al-Qaim, A Markov… - International …, 2021 - Elsevier
Cancer is a leading cause of death worldwide and imposes a substantial financial burden.
Therefore, it is essential to develop cost-effective approaches to inhibit tumor growth and …

[HTML][HTML] CXCR6 deficiency impairs cancer vaccine efficacy and CD8+ resident memory T-cell recruitment in head and neck and lung tumors

S Karaki, C Blanc, T Tran, I Galy-Fauroux… - … for Immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background Resident memory T lymphocytes (T RM) are located in tissues and play an
important role in immunosurveillance against tumors. The presence of T RM prior to …

CXCL13 and its receptor CXCR5 in cancer: inflammation, immune response, and beyond

MG Kazanietz, M Durando, M Cooke - Frontiers in endocrinology, 2019 - frontiersin.org
It is well-established that the chemokine CXC motif ligand 13 (CXCL13) and its receptor, the
G-protein coupled receptor (GPCR) CXCR5, play fundamental roles in inflammatory …

The role of stromal-derived factor-1—CXCR7 axis in development and cancer

RB Maksym, M Tarnowski, K Grymula… - European journal of …, 2009 - Elsevier
Cancer metastasis is a major clinical problem that contributes to unsuccessful therapy.
Augmenting evidence indicates that metastasizing cancer cells employ several mechanisms …